News › Clinical Practice, Industry News, Patient Care

Pain Control After Plastic Surgery

March 22, 2019

According to two new studies, plastic surgery patients are at significant risk of persistent opioid use; plastic surgeons prescribe nearly double the number of opioid tablets consumed after outpatient procedures; and guidelines are needed to better balance under- and over-prescribing of opioids after plastic surgery procedures.
In one study published March 7, 2019, in JAMA Facial Plastic Surgery researchers studied persistent opioid use after plastic and reconstructive surgery procedures of the nose, eye, breast, abdomen and soft tissue in a population of about 467,000 patients. They found about half of those patients filled prescriptions for postoperative pain relievers and nearly all the prescriptions filled were for opioids.
Read more at Dermatology Times >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • Merz Aesthetics’ Radiesse Receives FDA Approval for Décolleté Wrinkles
    • New Book “Get Found, Get Booked” Reveals a Smarter, Ethical Approach to Marketing for Med Spas and Wellness Practices
    • Growth, Capital and Control: Navigating Private Equity in Aesthetics
    • Med Spas Under the Microscope – The View From The FDA
    • Revance and Teoxane Announce RHA Dynamic Volume is Now Available